open access

Online first
Review paper
Published online: 2021-05-13
Get Citation

Fatty acids and aortic valve stenosis

Oscar Plunde, Magnus Bäck
DOI: 10.33963/KP.a2021.0003
·
Pubmed: 34002847

open access

Online first
Review article
Published online: 2021-05-13

Abstract

Aortic valve stenosis (AVS), a valvulopathy that threatens life quality and longevity, in particular in an aging population. Yet no medical treatment is to date available emphasizing the need for more mechanistic insight into the disease to provide future treatment targets. Obesity and genetic variants within genes involved in lipid metabolisms and lipoprotein (a) have emerged as risk factors for AVS as these variants have genome wide significant associations. The metamorphosis of the aortic valve to severe calcification involves lipid infiltration, inflammation, and oxidative stress which promotes further calcification in a viscous cycle in tandem with biomechanical factors that trigger further recruitment of inflammatory cells. The resolution of inflammation is an actively and regulated process which therefore offers new possible targets. Fatty acids serve as substrate for many lipid mediators involved in the resolution of inflammation which may counterbalance the inflammation by promoting macrophage-mediated healing leading to dampened inflammatory response. Recent data have put fatty acids in the spotlight as an important mechanisms in the development of aortic valve disease. In this review, discusses possible mechanisms exerted by fatty acids in the context of AVS to facilitate future search for therapeutic targets.

Abstract

Aortic valve stenosis (AVS), a valvulopathy that threatens life quality and longevity, in particular in an aging population. Yet no medical treatment is to date available emphasizing the need for more mechanistic insight into the disease to provide future treatment targets. Obesity and genetic variants within genes involved in lipid metabolisms and lipoprotein (a) have emerged as risk factors for AVS as these variants have genome wide significant associations. The metamorphosis of the aortic valve to severe calcification involves lipid infiltration, inflammation, and oxidative stress which promotes further calcification in a viscous cycle in tandem with biomechanical factors that trigger further recruitment of inflammatory cells. The resolution of inflammation is an actively and regulated process which therefore offers new possible targets. Fatty acids serve as substrate for many lipid mediators involved in the resolution of inflammation which may counterbalance the inflammation by promoting macrophage-mediated healing leading to dampened inflammatory response. Recent data have put fatty acids in the spotlight as an important mechanisms in the development of aortic valve disease. In this review, discusses possible mechanisms exerted by fatty acids in the context of AVS to facilitate future search for therapeutic targets.

Get Citation

Keywords

calcification, inflammation, lipid mediators, valvular heart disease

About this article
Title

Fatty acids and aortic valve stenosis

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Review paper

Published online

2021-05-13

DOI

10.33963/KP.a2021.0003

Pubmed

34002847

Keywords

calcification
inflammation
lipid mediators
valvular heart disease

Authors

Oscar Plunde
Magnus Bäck

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl